NCT04880928View on ClinicalTrials.gov

Comparison Mydriasis by Mydrane With Topical Drop Application

PHASE4CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

August 12, 2020

Primary Completion Date

September 23, 2021

Study Completion Date

September 23, 2021

Conditions
Cataract
Interventions
DRUG

Eye injection (Mydrane)

"Mydrane 0.2 mg/ml + 3.1 mg/ml~\+ 10 mg/ml solution for injection tropicamide / phenylephrine hydrochloride / lidocaine hydrochloride"

DRUG

eye drops (Phenylephrin)

Phenylephrine 10%

DRUG

eye drops (Tropicamid)

Tropicamid 0,5%

Trial Locations (1)

8036

Medical University Graz, Graz

All Listed Sponsors
lead

Medical University of Graz

OTHER

NCT04880928 - Comparison Mydriasis by Mydrane With Topical Drop Application | Biotech Hunter | Biotech Hunter